Skip to main content

Table 1 Association of Clinical and Laboratory variables with 30-day mortality in patients with alcoholic hepatitis.

From: Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

Variable   Number of patients 30-day mortality, % p Value
Age <46.5 17 6 0.09
  >46.5 17 35  
Gender Female 11 27 0.66
  Male 23 17  
Temperature <99.4 27 19 0.61
  >99.4 7 29  
Abdominal Pain Yes 13 23 1.00
  No 21 19  
Cirrhosis Yes 19 32 0.1
  No 15 7  
Encephalopathy Yes 11 45 0.02
  No 23 9  
Varices Yes 11 27 0.66
  No 23 17  
Splenomegaly Yes 9 33 0.35
  No 25 16  
Ascites Yes 17 41 <0.01
  No 17 0  
Bilirubin (mg/dL) <2 15 7 <0.01
  2–5 10 10  
  5–8 1 0  
  >8 8 63  
Albumin (g/dL) <3 13 38 0.02
  3–4 13 0  
  >4 1 0  
Creatinine (mg/dL) <1.5 27 15 0.13
  >1.5 7 43  
AST/ALT <1.2 3 0 0.12
  1.2–1.6 5 0  
  >1.6 17 27  
INR <1.5 20 5 0.01
  1.5–2.5 12 42  
  >1.6 2 50  
AST (U/L) <100 9 0 0.15
  >100 23 26  
ALT (U/L) <100 18 22 1.00
  >100 7 14  
WBC (× 109/L) <10 24 13 0.07
  >10 9 44  
Hemoglobin (g/dL) <10 10 20 1.00
  >10 23 22  
Platelet count (× 109/L) <50 3 33 0.52
  >50 30 20